House dust mite sublingual allergen immunotherapy tablet is safe and well-tolerated in Dutch clinical practice
Background Half (49%) of clinically diagnosed allergic rhinitis (AR) patients are sensitized to house dust mite (HDM). If allergen avoidance and symptomatic medication fail, allergen immunotherapy may be indicated. Objective We investigated safety and tolerability of HDM-sublingual immunotherapy by HDM-SLIT tablets in Dutch daily clinical practice. Methods Daily intake of 12 SQ-HDM SLIT-tablet was investigated in a prospective, multicenter, observational study (EUPAS43753). It comprised 4 consultations in 1 year. Data on safety, tolerability, treatment satisfaction, symptomatic medication, com... Mehr ...
Verfasser: | |
---|---|
Dokumenttyp: | Artikel |
Erscheinungsdatum: | 2024 |
Reihe/Periodikum: | Frontiers in Allergy ; volume 5 ; ISSN 2673-6101 |
Verlag/Hrsg.: |
Frontiers Media SA
|
Sprache: | unknown |
Permalink: | https://search.fid-benelux.de/Record/base-28996506 |
Datenquelle: | BASE; Originalkatalog |
Powered By: | BASE |
Link(s) : | http://dx.doi.org/10.3389/falgy.2024.1355324 |